WorldGate Communications' Unattributed VC - II Round

WorldGate Communications raised a round of funding on December 05, 2003.

Specializes in research, development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The company went public on February 1, 2005.…

Articles about WorldGate Communications' Unattributed VC - II Round: